TABLE 4.
Oral‐related symptoms in patients with SARS‐CoV‐2 infection
| Male (N = 52) | Female (N = 55 a ) | Total (N = 107 a ) | |
|---|---|---|---|
| Age (M ± SD) | 51.1 (15.26) | 52.9 (17.28) | 52.0 (16.28) |
| Oral‐related symptoms, n (%) | |||
| Male (N = 52) | Female (N = 56) | Total (N = 108) | |
| Initial symptoms, n (%) | |||
| Amblygeustia | 19 (36.5) | 32 (57.1) | 51 (47.2) |
| Dry mouth | 24 (46.2) | 26 (46.4) | 50 (46.3) |
| Dryness and inflammation of mouth | 7 (13.5) | 5 (8.9) | 12 (11.1) |
| Enlargement of lymph nodes in the submandibular regions | 0 | 1 (1.8) | 1 (0.9) |
a
Data on the age of 1 female patient were missing.